Sign in
4

Changes in Ownership

Boundless Bio, Inc. Filed Acc 0000950170-24-038695

Options or other derivatives

  • Chief Business Officer acquired 23,191 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Abdollahian Neil Chief Business Officer 2024-03-27 Grant or award · Stock Option +23,191 23,191 D: show line 1 in the form
Loading xslF345X05/ownership.xml…